{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:46:50Z","timestamp":1781214410876,"version":"3.54.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04515-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:40:19Z","timestamp":1752136819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Review: progression and heterogeneity of multiple sources of mesenchymal stromal\u00a0cells for the treatment of rheumatoid arthritis"],"prefix":"10.1186","volume":"16","author":[{"given":"Shiyi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-3675","authenticated-orcid":false,"given":"Zhenhua","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"4515_CR1","doi-asserted-by":"publisher","first-page":"152569","DOI":"10.1016\/j.semarthrit.2024.152569","volume":"69","author":"A Bounabe","year":"2024","unstructured":"Bounabe A, et al. Effectiveness of patient education on the quality of life of patients with rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2024;69:152569.","journal-title":"Semin Arthritis Rheum"},{"key":"4515_CR2","doi-asserted-by":"crossref","unstructured":"Dolcezza S et al. Relationship between rheumatoid arthritis and periodontal Disease-Systematic review and Meta-Analysis. J Clin Med, 2024. 14(1).","DOI":"10.3390\/jcm14010010"},{"key":"4515_CR3","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.gloepi.2024.100158","volume":"8","author":"O Mohamed-Ahmed","year":"2024","unstructured":"Mohamed-Ahmed O, et al. Incidence and prevalence of autoimmune diseases in china: A systematic review and meta-analysis of epidemiological studies. Glob Epidemiol. 2024;8:100158.","journal-title":"Glob Epidemiol"},{"issue":"3","key":"4515_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson DL, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the united States. Clin Immunol Immunopathol. 1997;84(3):223\u201343.","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"4515_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton WW, et al. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29(1):1\u20139.","journal-title":"J Autoimmun"},{"issue":"10","key":"4515_CR6","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18(10):591\u2013602.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"4515_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13287-025-04184-x","volume":"16","author":"L Zeng","year":"2025","unstructured":"Zeng L, et al. Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2025;16(1):65.","journal-title":"Stem Cell Res Ther"},{"issue":"40","key":"4515_CR8","doi-asserted-by":"publisher","first-page":"eabq0959","DOI":"10.1126\/sciadv.abq0959","volume":"8","author":"B Zhao","year":"2022","unstructured":"Zhao B, et al. NIR-photocatalytic regulation of arthritic synovial microenvironment. Sci Adv. 2022;8(40):eabq0959.","journal-title":"Sci Adv"},{"key":"4515_CR9","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3389\/fimmu.2017.01245","volume":"8","author":"MJE Marshall","year":"2017","unstructured":"Marshall MJE, Stopforth RJ, Cragg MS. Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going?? Front Immunol. 2017;8:1245.","journal-title":"Front Immunol"},{"key":"4515_CR10","doi-asserted-by":"crossref","unstructured":"England BR et al. 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures. Arthritis Care Res (Hoboken), 2019. 71(12): pp. 1540\u20131555.","DOI":"10.1002\/acr.24042"},{"issue":"7","key":"4515_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924\u201339.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10086","key":"4515_CR12","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338\u201348.","journal-title":"Lancet"},{"key":"4515_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/JIR.S219586","volume":"13","author":"R Harrington","year":"2020","unstructured":"Harrington R, Al Nokhatha SA, Conway R. JAK inhibitors in rheumatoid arthritis: an Evidence-Based review on the emerging clinical data. J Inflamm Res. 2020;13:519\u201331.","journal-title":"J Inflamm Res"},{"issue":"10","key":"4515_CR14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/acr2.11479","volume":"4","author":"MH Maqsood","year":"2022","unstructured":"Maqsood MH, et al. Cardiovascular and venous thromboembolic risk with Janus kinase inhibitors in Immune-Mediated inflammatory diseases: A systematic review and Meta-Analysis of randomized trials. ACR Open Rheumatol. 2022;4(10):912\u201322.","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"4515_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12015-020-09954-z","volume":"16","author":"A Karamini","year":"2020","unstructured":"Karamini A, et al. Therapeutic potential of mesenchymal stromal stem cells in rheumatoid arthritis: a systematic review of in vivo studies. Stem Cell Rev Rep. 2020;16(2):276\u201387.","journal-title":"Stem Cell Rev Rep"},{"key":"4515_CR16","doi-asserted-by":"crossref","unstructured":"McDonald J, Mohak S, Fabian Z. Stem Cell-Derived Extracell Vesicles Treat Cardiovasc Dis Pharm, 2024. 16(3).","DOI":"10.3390\/pharmaceutics16030381"},{"key":"4515_CR17","doi-asserted-by":"crossref","unstructured":"Patil H et al. CAR-T cell therapy in rheumatic diseases: a review Article. Clin Rheumatol, 2025.","DOI":"10.1007\/s10067-025-07451-7"},{"issue":"9","key":"4515_CR18","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/eji.202049064","volume":"51","author":"A Globerson Levin","year":"2021","unstructured":"Globerson Levin A, et al. CAR T cells: Building on the CD19 paradigm. Eur J Immunol. 2021;51(9):2151\u201363.","journal-title":"Eur J Immunol"},{"key":"4515_CR19","doi-asserted-by":"publisher","first-page":"1188049","DOI":"10.3389\/fimmu.2023.1188049","volume":"14","author":"A Mitra","year":"2023","unstructured":"Mitra A, et al. From bench to bedside: the history and progress of CAR T cell therapy. Front Immunol. 2023;14:1188049.","journal-title":"Front Immunol"},{"issue":"5391","key":"4515_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145\u20137.","journal-title":"Science"},{"issue":"8","key":"4515_CR21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.joms.2007.04.008","volume":"65","author":"RM Shanti","year":"2007","unstructured":"Shanti RM, et al. Adult mesenchymal stem cells: biological properties, characteristics, and applications in maxillofacial surgery. J Oral Maxillofac Surg. 2007;65(8):1640\u20137.","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"4515_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"key":"4515_CR23","doi-asserted-by":"publisher","first-page":"114017","DOI":"10.1016\/j.intimp.2025.114017","volume":"147","author":"Z Feng","year":"2025","unstructured":"Feng Z, et al. Application of cell therapy in rheumatoid arthritis: focusing on the Immunomodulatory strategies of mesenchymal stem cells. Int Immunopharmacol. 2025;147:114017.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4515_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13287-022-02763-w","volume":"13","author":"R Vij","year":"2022","unstructured":"Vij R, et al. Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase i\/iia, open-label, non-randomized pilot trial. Stem Cell Res Ther. 2022;13(1):88.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"4515_CR25","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.4103\/NRR.NRR-D-24-00129","volume":"20","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, et al. A vascular endothelial growth factor-loaded chitosan-hyaluronic acid hydrogel scaffold enhances the therapeutic effect of adipose-derived stem cells in the context of stroke. Neural Regen Res. 2025;20(12):3591\u2013605.","journal-title":"Neural Regen Res"},{"key":"4515_CR26","doi-asserted-by":"publisher","first-page":"156960","DOI":"10.1016\/j.cyto.2025.156960","volume":"191","author":"W Zou","year":"2025","unstructured":"Zou W, et al. Mesenchymal stem cell transplantation ameliorates inflammation in spinal cord injury by inhibiting lactylation-related genes. Cytokine. 2025;191:156960.","journal-title":"Cytokine"},{"key":"4515_CR27","doi-asserted-by":"publisher","first-page":"123608","DOI":"10.1016\/j.lfs.2025.123608","volume":"371","author":"B Zou","year":"2025","unstructured":"Zou B, et al. Mesenchymal stem cells attenuate hyperoxaluria-induced kidney injury and crystal depositions via inhibiting the activation of NLRP3 inflammasome. Life Sci. 2025;371:123608.","journal-title":"Life Sci"},{"issue":"3","key":"4515_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s12975-024-01274-5","volume":"16","author":"H Kang","year":"2025","unstructured":"Kang H, et al. Mesenchymal stem Cell-Loaded hydrogel improves surgical treatment for chronic cerebral ischemia. Transl Stroke Res. 2025;16(3):896\u2013913.","journal-title":"Transl Stroke Res"},{"issue":"1","key":"4515_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12891-025-08797-4","volume":"26","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Effect of intraarticular human umbilical cord mesenchymal stem cells transplantation on cartilage degradation and matrix metalloproteinases in OA rat model. BMC Musculoskelet Disord. 2025;26(1):538.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4515_CR30","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s42003-025-08261-y","volume":"8","author":"R Wang","year":"2025","unstructured":"Wang R, et al. Human placenta mesenchymal stromal cells alleviate intestinal inflammation and repair intestinal barrier function by activating AMPK-FXR pathway. Commun Biol. 2025;8(1):830.","journal-title":"Commun Biol"},{"issue":"1","key":"4515_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13287-025-04349-8","volume":"16","author":"J Shao","year":"2025","unstructured":"Shao J, et al. Human umbilical cord mesenchymal stem cell therapy for atopic dermatitis through Inhibition of neutrophil chemotaxis. Stem Cell Res Ther. 2025;16(1):243.","journal-title":"Stem Cell Res Ther"},{"key":"4515_CR32","doi-asserted-by":"crossref","unstructured":"El-Sayed SM, et al. Preconditioning of bone marrow mesenchymal stem cells with sodium hydrosulfide enhances their therapeutic potential in type II collagen-induced arthritis rat model. Naunyn Schmiedebergs Arch Pharmacol; 2025.","DOI":"10.1007\/s00210-025-04222-8"},{"key":"4515_CR33","doi-asserted-by":"crossref","unstructured":"Elhaieg A et al. Therapeutic potential of local and systemic Adipose-Derived mesenchymal stem cell injections in a rat model of experimental periodontitis: implications for cardiac function. Int J Mol Sci, 2025. 26(9).","DOI":"10.3390\/ijms26093984"},{"key":"4515_CR34","doi-asserted-by":"publisher","first-page":"102703","DOI":"10.1016\/j.tice.2024.102703","volume":"93","author":"M Abdelwahed","year":"2025","unstructured":"Abdelwahed M, et al. The potential of bone marrow derived mesenchymal stem cells in treating cisplatin induced sensorineural hearing loss in a guinea pig animal model. Tissue Cell. 2025;93:102703.","journal-title":"Tissue Cell"},{"issue":"1","key":"4515_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13287-025-04144-5","volume":"16","author":"L Wang","year":"2025","unstructured":"Wang L, et al. Adipose-derived stem cells attenuate rheumatoid arthritis by restoring CX(3)CR1(+) synovial lining macrophage barrier. Stem Cell Res Ther. 2025;16(1):111.","journal-title":"Stem Cell Res Ther"},{"key":"4515_CR36","doi-asserted-by":"crossref","unstructured":"Miao X et al. Extracellular vesicles as therapeutic agents in rheumatoid arthritis: a systematic review of current evidence. Inflammopharmacology, 2025.","DOI":"10.1007\/s10787-025-01670-9"},{"issue":"1","key":"4515_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/17460751.2025.2469426","volume":"20","author":"S Chen","year":"2025","unstructured":"Chen S, et al. BMSC-derived exosomes improve rheumatoid arthritis by regulating Th17 cell differentiation through targeting PRDM1. Regen Med. 2025;20(1):35\u201344.","journal-title":"Regen Med"},{"key":"4515_CR38","doi-asserted-by":"publisher","first-page":"p535361","DOI":"10.1155\/2012\/535361","volume":"2012","author":"J Chen","year":"2012","unstructured":"Chen J, et al. Comprehensive evaluation of different T-helper cell subsets differentiation and function in rheumatoid arthritis. J Biomed Biotechnol. 2012;2012:p535361.","journal-title":"J Biomed Biotechnol"},{"issue":"5 Suppl 46","key":"4515_CR39","first-page":"S4","volume":"25","author":"AP Cope","year":"2007","unstructured":"Cope AP, Schulze-Koops H, Aringer M. The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol. 2007;25(5 Suppl 46):S4\u201311.","journal-title":"Clin Exp Rheumatol"},{"key":"4515_CR40","doi-asserted-by":"publisher","first-page":"102555","DOI":"10.1016\/j.coi.2025.102555","volume":"94","author":"CS Savvides","year":"2025","unstructured":"Savvides CS, James EA, Buckner JH. Rheumatoid arthritis - the role of T cells in this complex systemic autoimmune disease. Curr Opin Immunol. 2025;94:102555.","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"4515_CR41","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s00296-011-1984-x","volume":"32","author":"Q Niu","year":"2012","unstructured":"Niu Q, et al. Disturbed Th17\/Treg balance in patients with rheumatoid arthritis. Rheumatol Int. 2012;32(9):2731\u20136.","journal-title":"Rheumatol Int"},{"issue":"5","key":"4515_CR42","doi-asserted-by":"publisher","first-page":"e70189","DOI":"10.1002\/iid3.70189","volume":"13","author":"HF Hetta","year":"2025","unstructured":"Hetta HF, et al. Clinical progress in mesenchymal stem cell therapy: A focus on rheumatic diseases. Immun Inflamm Dis. 2025;13(5):e70189.","journal-title":"Immun Inflamm Dis"},{"issue":"8","key":"4515_CR43","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/j.1600-6143.2009.02721.x","volume":"9","author":"W Ge","year":"2009","unstructured":"Ge W, et al. Infusion of mesenchymal stem cells and Rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transpl. 2009;9(8):1760\u201372.","journal-title":"Am J Transpl"},{"issue":"34","key":"4515_CR44","doi-asserted-by":"publisher","first-page":"eabn8614","DOI":"10.1126\/sciadv.abn8614","volume":"8","author":"TT Nguyen","year":"2022","unstructured":"Nguyen TT, et al. Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for Immunomodulating effect in islet xenotransplantation. Sci Adv. 2022;8(34):eabn8614.","journal-title":"Sci Adv"},{"issue":"4","key":"4515_CR45","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE. 2010;5(4):e10088.","journal-title":"PLoS ONE"},{"key":"4515_CR46","doi-asserted-by":"publisher","first-page":"708186","DOI":"10.3389\/fimmu.2021.708186","volume":"12","author":"EA Ross","year":"2021","unstructured":"Ross EA, Devitt A, Johnson JR. Macrophages: the good, the bad, and the gluttony. Front Immunol. 2021;12:708186.","journal-title":"Front Immunol"},{"key":"4515_CR47","doi-asserted-by":"crossref","unstructured":"Roszkowski L, Ciechomska M. Tuning monocytes and macrophages for personalized therapy and diagnostic challenge in rheumatoid arthritis. Cells, 2021. 10(8).","DOI":"10.3390\/cells10081860"},{"issue":"1","key":"4515_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12951-024-02711-1","volume":"22","author":"Q Yan","year":"2024","unstructured":"Yan Q, et al. Adipose-derived stem cell exosomes loaded with Icariin alleviates rheumatoid arthritis by modulating macrophage polarization in rats. J Nanobiotechnol. 2024;22(1):423.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4515_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14\u201320.","journal-title":"Immunity"},{"issue":"9","key":"4515_CR50","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.4252\/wjsc.v13.i9.1160","volume":"13","author":"AN Sant\u2019Ana","year":"2021","unstructured":"Sant\u2019Ana AN, et al. Effects of living and metabolically inactive mesenchymal stromal cells and their derivatives on monocytes and macrophages. World J Stem Cells. 2021;13(9):1160\u201376.","journal-title":"World J Stem Cells"},{"issue":"7","key":"4515_CR51","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.joca.2017.01.011","volume":"25","author":"C Manferdini","year":"2017","unstructured":"Manferdini C, et al. Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro evaluation. Osteoarthritis Cartilage. 2017;25(7):1161\u201371.","journal-title":"Osteoarthritis Cartilage"},{"issue":"5","key":"4515_CR52","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.joca.2019.12.007","volume":"28","author":"CL Wu","year":"2020","unstructured":"Wu CL, et al. The role of macrophages in osteoarthritis and cartilage repair. Osteoarthritis Cartilage. 2020;28(5):544\u201354.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"4515_CR53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12951-025-03216-1","volume":"23","author":"J Zhan","year":"2025","unstructured":"Zhan J, et al. MSCs-EVs harboring OA immune memory reprogram macrophage phenotype via modulation of the mt-ND3\/NADH-CoQ axis for OA treatment. J Nanobiotechnol. 2025;23(1):140.","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"4515_CR54","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/stcltm\/szac075","volume":"11","author":"MJ Alcaraz","year":"2022","unstructured":"Alcaraz MJ, Guill\u00e9n MI. Cellular and molecular targets of extracellular vesicles from mesenchymal stem\/stromal cells in rheumatoid arthritis. Stem Cells Transl Med. 2022;11(12):1177\u201385.","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"4515_CR55","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1093\/ndt\/gfs168","volume":"27","author":"L Biancone","year":"2012","unstructured":"Biancone L, et al. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transpl. 2012;27(8):3037\u201342.","journal-title":"Nephrol Dial Transpl"},{"key":"4515_CR56","doi-asserted-by":"publisher","first-page":"1543702","DOI":"10.3389\/fimmu.2025.1543702","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, et al. Remodeling the intestinal immune microenvironment: immune regulation and tissue regeneration by mesenchymal stem\/stromal cells in the repair microenvironment of inflammatory bowel disease. Front Immunol. 2025;16:1543702.","journal-title":"Front Immunol"},{"issue":"1","key":"4515_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13287-025-04197-6","volume":"16","author":"W Jiang","year":"2025","unstructured":"Jiang W, et al. Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p\/STING axis. Stem Cell Res Ther. 2025;16(1):74.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4515_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13287-020-02068-w","volume":"12","author":"J Sun","year":"2021","unstructured":"Sun J, et al. microRNA-27b shuttled by mesenchymal stem cell-derived exosomes prevents sepsis by targeting JMJD3 and downregulating NF-\u03baB signaling pathway. Stem Cell Res Ther. 2021;12(1):14.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"4515_CR59","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/stem.2564","volume":"35","author":"Y Song","year":"2017","unstructured":"Song Y, et al. Exosomal miR-146a contributes to the enhanced therapeutic efficacy of Interleukin-1\u03b2-Primed mesenchymal stem cells against Sepsis. Stem Cells. 2017;35(5):1208\u201321.","journal-title":"Stem Cells"},{"issue":"4","key":"4515_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s13770-020-00324-x","volume":"18","author":"M Kim","year":"2021","unstructured":"Kim M, et al. Exosomes from IL-1\u03b2-Primed mesenchymal stem cells inhibited IL-1\u03b2- and TNF-\u03b1-Mediated inflammatory responses in Osteoarthritic SW982 cells. Tissue Eng Regen Med. 2021;18(4):525\u201336.","journal-title":"Tissue Eng Regen Med"},{"issue":"7","key":"4515_CR61","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/cvr\/cvz040","volume":"115","author":"J Zhao","year":"2019","unstructured":"Zhao J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115(7):1205\u201316.","journal-title":"Cardiovasc Res"},{"key":"4515_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jtos.2023.03.002","volume":"28","author":"L Wang","year":"2023","unstructured":"Wang L, et al. MicroRNAs of extracellular vesicles derived from mesenchymal stromal cells alleviate inflammation in dry eye disease by targeting the IRAK1\/Table 2\/NF-\u03baB pathway. Ocul Surf. 2023;28:131\u201340.","journal-title":"Ocul Surf"},{"issue":"1","key":"4515_CR63","doi-asserted-by":"publisher","first-page":"102102","DOI":"10.1016\/j.omtn.2023.102102","volume":"35","author":"WT Lin","year":"2024","unstructured":"Lin WT, et al. Modulation of experimental acute lung injury by Exosomal miR-7704 from mesenchymal stromal cells acts through M2 macrophage polarization. Mol Ther Nucleic Acids. 2024;35(1):102102.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4515_CR64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jare.2023.12.006","volume":"65","author":"J Chen","year":"2024","unstructured":"Chen J, et al. The NLRP3 molecule influences the therapeutic effects of mesenchymal stem cells through Glut1-mediated energy metabolic reprogramming. J Adv Res. 2024;65:125\u201336.","journal-title":"J Adv Res"},{"issue":"10","key":"4515_CR65","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/stem.1191","volume":"30","author":"JH Yl\u00f6stalo","year":"2012","unstructured":"Yl\u00f6stalo JH, et al. Human mesenchymal stem\/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells. 2012;30(10):2283\u201396.","journal-title":"Stem Cells"},{"issue":"9","key":"4515_CR66","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1634\/stemcells.2006-0686","volume":"25","author":"SC Hung","year":"2007","unstructured":"Hung SC, et al. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells. 2007;25(9):2363\u201370.","journal-title":"Stem Cells"},{"key":"4515_CR67","doi-asserted-by":"publisher","first-page":"749192","DOI":"10.3389\/fimmu.2021.749192","volume":"12","author":"Z Shen","year":"2021","unstructured":"Shen Z, et al. Effects of mesenchymal stem Cell-Derived exosomes on autoimmune diseases. Front Immunol. 2021;12:749192.","journal-title":"Front Immunol"},{"key":"4515_CR68","doi-asserted-by":"publisher","first-page":"p113072","DOI":"10.1016\/j.intimp.2024.113072","volume":"142Pt A","author":"H Ye","year":"2024","unstructured":"Ye H, et al. Exosomal LncRNA TUG1 derived from BMSC ameliorate collagen-induced arthritis via BLIMP1-mediated Th17\/Treg balance. Int Immunopharmacol. 2024;142Pt A:p113072.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4515_CR69","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1186\/s12951-024-02922-6","volume":"22","author":"S Wei","year":"2024","unstructured":"Wei S, et al. MSC-microvesicles protect cartilage from degradation in early rheumatoid arthritis via immunoregulation. J Nanobiotechnol. 2024;22(1):673.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"4515_CR70","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/jars.2002.32839","volume":"18","author":"K Hjelle","year":"2002","unstructured":"Hjelle K, et al. Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy. 2002;18(7):730\u20134.","journal-title":"Arthroscopy"},{"issue":"3","key":"4515_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.knee.2007.02.001","volume":"14","author":"W Widuchowski","year":"2007","unstructured":"Widuchowski W, Widuchowski J, Trzaska T. Articular cartilage defects: study of 25,124 knee arthroscopies. Knee. 2007;14(3):177\u201382.","journal-title":"Knee"},{"issue":"9","key":"4515_CR72","doi-asserted-by":"publisher","first-page":"e2303300","DOI":"10.1002\/adhm.202303300","volume":"13","author":"J Gan","year":"2024","unstructured":"Gan J, et al. CXCR4-Expressing mesenchymal stem cells derived nanovesicles for rheumatoid arthritis treatment. Adv Healthc Mater. 2024;13(9):e2303300.","journal-title":"Adv Healthc Mater"},{"issue":"36","key":"4515_CR73","doi-asserted-by":"publisher","first-page":"47206","DOI":"10.1021\/acsami.4c09080","volume":"16","author":"L Ma","year":"2024","unstructured":"Ma L, et al. Mesenchymal stem Cell-Based biomimetic liposome for targeted treatment of rheumatoid arthritis. ACS Appl Mater Interfaces. 2024;16(36):47206\u201315.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4515_CR74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coph.2018.03.009","volume":"40","author":"C De Bari","year":"2018","unstructured":"De Bari C, Roelofs AJ. Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis. Curr Opin Pharmacol. 2018;40:74\u201380.","journal-title":"Curr Opin Pharmacol"},{"key":"4515_CR75","doi-asserted-by":"crossref","unstructured":"Huang Y et al. Mechanism of berbamine-mediated DNA damage in synovial fibroblasts to alleviate rheumatoid arthritis. Eur J Pharmacol, 2025: p. 177597.","DOI":"10.1016\/j.ejphar.2025.177597"},{"issue":"Pt 2","key":"4515_CR76","doi-asserted-by":"publisher","first-page":"113340","DOI":"10.1016\/j.intimp.2024.113340","volume":"143","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Human umbilical mesenchymal stem cell-derived exosomes alleviate bone destruction and regulate bone immunity via the Aryl hydrocarbon receptor to treat rheumatoid arthritis. Int Immunopharmacol. 2024;143(Pt 2):113340.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4515_CR77","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13287-024-03887-x","volume":"15","author":"MT Jouybari","year":"2024","unstructured":"Jouybari MT, et al. Advancements in extracellular vesicle targeted therapies for rheumatoid arthritis: insights into cellular origins, current perspectives, and emerging challenges. Stem Cell Res Ther. 2024;15(1):276.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4515_CR78","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s10020-024-00967-9","volume":"30","author":"Q Xu","year":"2024","unstructured":"Xu Q, et al. Mesenchymal stem cells lineage and their role in disease development. Mol Med. 2024;30(1):207.","journal-title":"Mol Med"},{"issue":"1","key":"4515_CR79","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1186\/s12967-024-05814-3","volume":"22","author":"H Sun","year":"2024","unstructured":"Sun H, et al. Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence. J Transl Med. 2024;22(1):1039.","journal-title":"J Transl Med"},{"issue":"5","key":"4515_CR80","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294\u2013301.","journal-title":"Stem Cells"},{"issue":"3","key":"4515_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s007740050081","volume":"17","author":"S Nishida","year":"1999","unstructured":"Nishida S, et al. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Min Metab. 1999;17(3):171\u20137.","journal-title":"J Bone Min Metab"},{"issue":"6","key":"4515_CR82","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bone.2003.07.005","volume":"33","author":"K Stenderup","year":"2003","unstructured":"Stenderup K, et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33(6):919\u201326.","journal-title":"Bone"},{"key":"4515_CR83","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.biopha.2018.11.056","volume":"109","author":"M Ghoryani","year":"2019","unstructured":"Ghoryani M, et al. Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: A successful clinical trial in Iran. Biomed Pharmacother. 2019;109:1834\u201340.","journal-title":"Biomed Pharmacother"},{"key":"4515_CR84","doi-asserted-by":"publisher","first-page":"3562753","DOI":"10.1155\/2020\/3562753","volume":"2020","author":"M Ghoryani","year":"2020","unstructured":"Ghoryani M, et al. The sufficient immunoregulatory effect of autologous bone Marrow-Derived mesenchymal stem cell transplantation on regulatory T cells in patients with refractory rheumatoid arthritis. J Immunol Res. 2020;2020:3562753.","journal-title":"J Immunol Res"},{"issue":"12","key":"4515_CR85","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/17460751.2024.2443352","volume":"19","author":"A Jamshidi","year":"2024","unstructured":"Jamshidi A, et al. Allogeneic bone marrow derived clonal mesenchymal stromal cells in refractory rheumatoid arthritis: a pilot study. Regen Med. 2024;19(12):599\u2013609.","journal-title":"Regen Med"},{"issue":"24","key":"4515_CR86","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1089\/scd.2013.0023","volume":"22","author":"L Wang","year":"2013","unstructured":"Wang L, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192\u2013202.","journal-title":"Stem Cells Dev"},{"issue":"4","key":"4515_CR87","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/bmt.2012.184","volume":"48","author":"X Li","year":"2013","unstructured":"Li X, et al. Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus. Bone Marrow Transpl. 2013;48(4):544\u201350.","journal-title":"Bone Marrow Transpl"},{"key":"4515_CR88","doi-asserted-by":"crossref","unstructured":"Chen J et al. miRNA-148a-containing GMSC-derived EVs modulate Treg\/Th17 balance via IKKB\/NF-\u03baB pathway and treat a rheumatoid arthritis model. JCI Insight, 2024. 9(10).","DOI":"10.1172\/jci.insight.177841"},{"issue":"16","key":"4515_CR89","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1073\/pnas.1000302107","volume":"107","author":"C Scotti","year":"2010","unstructured":"Scotti C, et al. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A. 2010;107(16):7251\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11\u201312","key":"4515_CR90","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1089\/ten.tea.2011.0544","volume":"18","author":"T Vinardell","year":"2012","unstructured":"Vinardell T, et al. A comparison of the functionality and in vivo phenotypic stability of cartilaginous tissues engineered from different stem cell sources. Tissue Eng Part A. 2012;18(11\u201312):1161\u201370.","journal-title":"Tissue Eng Part A"},{"issue":"7","key":"4515_CR91","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1182\/blood.V81.7.1679.1679","volume":"81","author":"P Rubinstein","year":"1993","unstructured":"Rubinstein P, et al. Stored placental blood for unrelated bone marrow reconstitution. Blood. 1993;81(7):1679\u201390.","journal-title":"Blood"},{"issue":"8","key":"4515_CR92","first-page":"1017","volume":"91","author":"LL Lu","year":"2006","unstructured":"Lu LL, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91(8):1017\u201326.","journal-title":"Haematologica"},{"issue":"6","key":"4515_CR93","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1634\/stemcells.2006-0709","volume":"25","author":"D Baksh","year":"2007","unstructured":"Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6):1384\u201392.","journal-title":"Stem Cells"},{"issue":"34","key":"4515_CR94","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1016\/j.biomaterials.2005.05.022","volume":"26","author":"Y Wang","year":"2005","unstructured":"Wang Y, et al. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials. 2005;26(34):7082\u201394.","journal-title":"Biomaterials"},{"key":"4515_CR95","doi-asserted-by":"crossref","unstructured":"\u00c1lvaro-Gracia JM et al. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase ib\/iia clinical trial. in Ann Rheum Dis. 2017. pp. 196\u2013202.","DOI":"10.1136\/annrheumdis-2015-208918"},{"issue":"3","key":"4515_CR96","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/art.10118","volume":"46","author":"JM Murphy","year":"2002","unstructured":"Murphy JM, et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 2002;46(3):704\u201313.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4515_CR97","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cbf.1488","volume":"26","author":"Y Zhu","year":"2008","unstructured":"Zhu Y, et al. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct. 2008;26(6):664\u201375.","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"4515_CR98","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.scr.2013.05.008","volume":"11","author":"M Maumus","year":"2013","unstructured":"Maumus M, et al. Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis. Stem Cell Res. 2013;11(2):834\u201344.","journal-title":"Stem Cell Res"},{"issue":"11","key":"4515_CR99","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1002\/art.34626","volume":"64","author":"M ter Huurne","year":"2012","unstructured":"ter Huurne M, et al. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum. 2012;64(11):3604\u201313.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4515_CR100","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.knee.2010.03.001","volume":"18","author":"FS Toghraie","year":"2011","unstructured":"Toghraie FS, et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Knee. 2011;18(2):71\u20135.","journal-title":"Knee"},{"issue":"13","key":"4515_CR101","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/hepr.12507","volume":"45","author":"S Shiratsuki","year":"2015","unstructured":"Shiratsuki S, et al. Enhanced survival of mice infused with bone marrow-derived as compared with adipose-derived mesenchymal stem cells. Hepatol Res. 2015;45(13):1353\u20139.","journal-title":"Hepatol Res"},{"issue":"7","key":"4515_CR102","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1177\/0363546519848678","volume":"47","author":"W Zhou","year":"2019","unstructured":"Zhou W, et al. Single-Cell profiles and clinically useful properties of human mesenchymal stem cells of adipose and bone marrow origin. Am J Sports Med. 2019;47(7):1722\u201333.","journal-title":"Am J Sports Med"},{"issue":"6","key":"4515_CR103","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/sctm.18-0122","volume":"8","author":"WS Lee","year":"2019","unstructured":"Lee WS, et al. Intra-Articular injection of autologous adipose Tissue-Derived mesenchymal stem cells for the treatment of knee osteoarthritis: A phase iib, randomized, Placebo-Controlled clinical trial. Stem Cells Transl Med. 2019;8(6):504\u201311.","journal-title":"Stem Cells Transl Med"},{"key":"4515_CR104","doi-asserted-by":"publisher","first-page":"177543","DOI":"10.1016\/j.ejphar.2025.177543","volume":"998","author":"C Chen","year":"2025","unstructured":"Chen C, et al. New perspectives on the treatment of diabetic nephropathy: challenges and prospects of mesenchymal stem cell therapy. Eur J Pharmacol. 2025;998:177543.","journal-title":"Eur J Pharmacol"},{"key":"4515_CR105","doi-asserted-by":"publisher","first-page":"153756","DOI":"10.1016\/j.prp.2021.153756","volume":"230","author":"M Carmona","year":"2022","unstructured":"Carmona M, et al. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal\/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy. Pathol Res Pract. 2022;230:153756.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"4515_CR106","doi-asserted-by":"publisher","first-page":"e0210250","DOI":"10.1371\/journal.pone.0210250","volume":"14","author":"LR Devireddy","year":"2019","unstructured":"Devireddy LR, et al. A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem\/stromal cells. PLoS ONE. 2019;14(2):e0210250.","journal-title":"PLoS ONE"},{"issue":"1","key":"4515_CR107","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13287-022-02815-1","volume":"13","author":"S Palombella","year":"2022","unstructured":"Palombella S, et al. Systematic review and meta-analysis on the use of human platelet lysate for mesenchymal stem cell cultures: comparison with fetal bovine serum and considerations on the production protocol. Stem Cell Res Ther. 2022;13(1):142.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4515_CR108","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13287-024-03954-3","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Li R. Effects, methods and limits of the cryopreservation on mesenchymal stem cells. Stem Cell Res Ther. 2024;15(1):337.","journal-title":"Stem Cell Res Ther"},{"key":"4515_CR109","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.reth.2025.01.024","volume":"29","author":"S Terai","year":"2025","unstructured":"Terai S, et al. Recommendations for the safe implementation of intravenous administration of mesenchymal stromal cells. Regen Ther. 2025;29:171\u20136.","journal-title":"Regen Ther"},{"issue":"9","key":"4515_CR110","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/sctm.18-0031","volume":"7","author":"EH Park","year":"2018","unstructured":"Park EH, et al. Intravenous infusion of umbilical cord Blood-Derived mesenchymal stem cells in rheumatoid arthritis: A phase Ia clinical trial. Stem Cells Transl Med. 2018;7(9):636\u201342.","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"4515_CR111","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/stem.1634","volume":"32","author":"CH Jo","year":"2014","unstructured":"Jo CH, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32(5):1254\u201366.","journal-title":"Stem Cells"},{"issue":"8","key":"4515_CR112","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/TP.0000000000000678","volume":"99","author":"A Vega","year":"2015","unstructured":"Vega A, et al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: A randomized controlled trial. Transplantation. 2015;99(8):1681\u201390.","journal-title":"Transplantation"},{"issue":"1","key":"4515_CR113","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM \u00c1lvaro-Gracia","year":"2017","unstructured":"\u00c1lvaro-Gracia JM, et al. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase ib\/iia clinical trial. Ann Rheum Dis. 2017;76(1):196\u2013202.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4515_CR114","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/mt.2011.189","volume":"20","author":"M Fran\u00e7ois","year":"2012","unstructured":"Fran\u00e7ois M, et al. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2012;20(1):187\u201395.","journal-title":"Mol Ther"},{"key":"4515_CR115","doi-asserted-by":"crossref","unstructured":"Lee MH et al. Genome editing using CRISPR-Cas9 and autoimmune diseases: A comprehensive review. Int J Mol Sci, 2022. 23(3).","DOI":"10.3390\/ijms23031337"},{"issue":"10","key":"4515_CR116","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1021\/acs.nanolett.4c05782","volume":"25","author":"M Chen","year":"2025","unstructured":"Chen M, et al. Biomimetic nanoparticles inhibit the HIF-1\u03b1\/iNOS\/NLRP3 pathway to alleviate rheumatoid arthritis. Nano Lett. 2025;25(10):3807\u201316.","journal-title":"Nano Lett"},{"key":"4515_CR117","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.2147\/IJN.S334298","volume":"16","author":"MJ Shin","year":"2021","unstructured":"Shin MJ, et al. Stem cell mimicking nanoencapsulation for targeting arthritis. Int J Nanomed. 2021;16:8485\u2013507.","journal-title":"Int J Nanomed"},{"issue":"10","key":"4515_CR118","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s00210-023-02514-5","volume":"396","author":"R Rani","year":"2023","unstructured":"Rani R, et al. Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(10):2287\u2013310.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"4515_CR119","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.apsb.2023.04.003","volume":"13","author":"G Shi","year":"2023","unstructured":"Shi G, et al. Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A(2A\/2B) receptors in tolerogenic dendritic cells. Acta Pharm Sin B. 2023;13(6):2778\u201394.","journal-title":"Acta Pharm Sin B"},{"key":"4515_CR120","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.actbio.2020.12.005","volume":"121","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, et al. Infliximab-based self-healing hydrogel composite scaffold enhances stem cell survival, engraftment, and function in rheumatoid arthritis treatment. Acta Biomater. 2021;121:653\u201364.","journal-title":"Acta Biomater"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04515-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:29:07Z","timestamp":1757219347000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04515-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4515"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04515-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"358"}}